1. Home
  2. RMTI vs JSPR Comparison

RMTI vs JSPR Comparison

Compare RMTI & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rockwell Medical Inc.

RMTI

Rockwell Medical Inc.

N/A

Current Price

$7.75

Market Cap

29.9M

Sector

Health Care

ML Signal

N/A

Logo Jasper Therapeutics Inc.

JSPR

Jasper Therapeutics Inc.

HOLD

Current Price

$0.70

Market Cap

26.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RMTI
JSPR
Founded
1994
2018
Country
United States
United States
Employees
300
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.9M
26.3M
IPO Year
2022
2019

Fundamental Metrics

Financial Performance
Metric
RMTI
JSPR
Price
$7.75
$0.70
Analyst Decision
Strong Buy
Buy
Analyst Count
1
11
Target Price
$2.00
$15.50
AVG Volume (30 Days)
26.4K
717.2K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
19.22
EPS
N/A
N/A
Revenue
$69,258,000.00
N/A
Revenue This Year
$8.64
N/A
Revenue Next Year
$8.44
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.55
$0.32
52 Week High
$8.40
$2.87

Technical Indicators

Market Signals
Indicator
RMTI
JSPR
Relative Strength Index (RSI) 65.84 49.12
Support Level $0.80 $0.61
Resistance Level $7.81 $1.01
Average True Range (ATR) 0.49 0.10
MACD -0.09 -0.01
Stochastic Oscillator 66.66 15.81

Price Performance

Historical Comparison
RMTI
JSPR

About RMTI Rockwell Medical Inc.

Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.

About JSPR Jasper Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.

Share on Social Networks: